DOCSLIB.ORG

Radiation Oncology Services

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Radiation Oncology Services Radiation Oncology Services Potomac R. Patient name: Comprehensive Multidisciplinary CareLovettsville Referred by: • 3-Dimensional Treatment Planning WaterfordReason for referral: • Intensity Modulated Radiation Therapy (IMRT) 15 • Image-Guided Radiation Therapy (IGRT) Leesburg • Cyberknife Stereotactic Body Radiation Therapy (SBRT) for brain, spine, liver, prostate Locations: and lung tumors 3 1. Inova Cancer Center - Fairfax Radiation Oncology Ashburn • Brachytherapy (Implants)50 for prostate, 495 3300 Gallows Road Sterling 7 gynecologic and other cancers Falls Church, VA 22042 Reston 703.776.3731 • Fax: 703.776.2743 • Partial Breast Irradiation and intraoperative irradiation for breast cancer 50 2. Coming 2014 2 495 Inova Cancer Center - Fair Oaks • Pediatric Radiation Therapy 3580 Joseph Siewick Drive Centreville Fairfax, VA 22033 • Palliative Radiation Therapy 66 Fairfax 1 3. Inova Cancer Center - Loudoun • Theraspheres and Sirspheres for liver tumors Fairfax County 44045 Riverside Parkway • Radium - 223 and Samarium for 395 Leesburg, VA 20176 703.858.8850 • Fax: 703.858.8870 bone metastases Mount Vernon 4. Potomac Radiation Oncology Center • Treatment of skin cancers, including Lake Ridge A service of Inova and Sentara Healthcare cutting-edge brachytherapy 2280 Opitz Boulevard, Suite #120 4 Woodbridge Woodbridge, VA 22191 703.670.3349 • Fax: 703.590.3199 Instructions To Patients:Quantico Your first visit will be a consultation with one of the physicians. Please bring any scans (film or CD) and relevant medical records to this appointment. For more information and registration forms, go to inova.org/radonc Our Board-Certified Physician Team Stella Hetelekidis, MD Joseph Lee, MD, PhD Our team treats more radiation therapy patients Chairman, Department of Radiation * MD and PhD, University of Minnesota than any other hospital in the Washington, Oncology, Inova Fairfax Hospital * Residency, Mallinckrodt Institute of DC area. Our Radiation Oncology Department • MD, University of Rochester Radiology at Washington University includes board-certified, experienced radiation Medical School in St Louis / Barnes-Jewish Hospital oncologists who are routinely ranked as “Top • Residency, Joint Center for Doctors” in Washingtonian, US News & World Radiation Therapy, Harvard Report, and Northern Virginia magazines. Medical School Samir Kanani, MD • Former faculty at Duke University Medical Director, Radiation Oncology, Our integrated team also includes board- and Harvard University Inova Loudoun Hospital certified medical physicists, dosimetrists, Medical Director, Cyberknife Brain and Gopal Bajaj, MD certified radiation therapists, certified clinical Spine Radiosurgery Program Medical Director, Upper Aerodigestive and social workers, certified oncology dietitians and Thoracic Malignancy Program • MD, University of Texas Medical outstanding and caring oncology nurses. Medical Director, Cyberknife Body School at Galveston Our physicians specialize in a vast array of Radiosurgery Program • Residency, University of Maryland cutting-edge technologies at the forefront of • MD, University of Kansas Glenn Tonnesen, MD the fight against cancer, including Intensity Medical School • MD, University of Utah College Modulated Radiation Therapy, Stereotactic • Residency, Johns Hopkins Hospital (chief resident) of Medicine Radiosurgery, Stereotactic Body Radiation • Former faculty at Johns Hopkins • Residency, Joint Center for Therapy and High Dose Rate Brachytherapy. University Radiation Therapy, Harvard We offer a multidisciplinary approach and work Medical School closely with our colleagues in surgical and Susan Boylan, MD • Former faculty at Harvard University medical oncology to provide our patients with Medical Director, Radiation Oncology, • Former Chief, Radiation Oncology, Sentara Northern Virginia Medical Center the most complete and advanced care. Bethesda Naval Hospital • MD, Georgetown University • Former Chairman, Inova Fairfax • Residency, North Carolina Baptist Hospital Radiation Oncology Hospital, Wake Forest University • Additional Board Certification Internal Medicine Ashish K. Chawla, MD Learn more at inova.org/radonc Medical Director, Radiation Oncology, Inova Fair Oaks Hospital All five Inova hospitals are ranked in the top 15 Medical Director, Partial Breast Irradiation hospitals in the Washington, DC metro area for Program 2013-2014 by U.S. News & World Report, including Inova Fairfax Hospital, ranked #1 in the region. • MD, Thomas Jefferson University • Residency, Massachusetts General Hospital, Harvard Medical School G32184/9-13/200pdsx50s.
Load more

Recommended publications
  • QUEST Provider Bulletin
    HMSA Provider Bulletin HMS A ’ S P L an fo R Q U E S T M embe R S Bulletin Q08-01 January 15, 2008 A MESSAGE FROM OUR appointments, ensuring the collection and forwarding of MEDICAL DIRECTOR necessary information, obtaining prior authorizations, educating the parents, and following up to ensure appointments are kept is Children with Special Health Care Needs guaranteed to be difficult and time consuming. Children with chronic illnesses are Other examples include children with diabetes, congenital heart challenging for pediatricians and other defects, seizure disorders, asthma, cancer (even if in remission), primary care providers entrusted with and juvenile rheumatoid arthritis. Also included are children their care. This is especially so for with multiple diagnoses, related or otherwise. those children whose management The Hawaii Department of Health has a service dedicated to requires the services of various assisting such children, their families and their caregivers. This medical specialists, allied health care is the Children with Special Health Needs Program, under the providers, organizations, and institutions. A child with Family Health Services Division. Children and youth under 21 a cleft palate, for example, may require the services of years of age residing in Hawaii are eligible if they have chronic an ENT surgeon, oral surgeon, dentist, audiologist, health conditions lasting (or expected to last) at least one year, speech therapist, DME provider (for hearing aids), for which specialized medical care is required. and the Department of Education. Locating these The Children with Special Health Needs Program can assist providers, making the necessary referrals, coordinating QUEST members who are having difficulty in coordinating or obtaining health care services, or who cannot obtain certain Happy New Year 2008 services through QUEST, with the following: IN THIS ISSUE: • Coordination of health care referrals and appointments.
    [Show full text]
  • Radiation Therapy – a Technicians Overview By: Stephanie Corsi, CVT
    Radiation Therapy – A technicians overview By: Stephanie Corsi, CVT Senior Radiation Oncology nurse, PennVet What is radiation therapy? Radiation therapy uses high-energy radiation or high energy particle (electrons) to kill cancer cells and shrink tumors. How does radiation therapy work? Radiation kills cancer cells by damaging their DNA. Cells that are rapidly dividing, like cancer cells, are more susceptible to radiation. The damage is by a high energy photon ejecting a high energy electron that then reacts with a water molecule to create charged particle, also called free radicals, within the cell that will damage the DNA. Most cells die what is called a “mitotic death”, meaning the cancer cells whose DNA is damaged beyond repair will stop dividing and die. Goal of Radiation: The purpose of radiation is to maximize the likelihood of tumor control while minimizing side-effects to the patient. Radiation may be used alone or in combination with surgery, chemotherapy, or both. “Curative” intent/ definitive therapy: This is given when the prognosis is good. The hope is that treatment will cure a cancer by eliminating a tumor and preventing recurrence. For tumors that are inherently sensitive, relatively small, and localized. Also used to treat residual cancer left behind after surgery, or before surgery to shrink a tumor. Examples: localized lymphomas, certain mast cell tumors, cutaneous squamous cell carcinomas Palliative intent: Not intended to cure, but rather relieve symptoms and reduce suffering. Given when prognosis is poor and quality of life is the primary focus. Used with bulky tumors. Examples: alleviate bone pain associated with osteosarcoma, a tumor pressing on the spine, tumors pressing on the esophagus interfering with breathing/eating, etc.
    [Show full text]
  • Clinical Outcomes and Prognostic Factors of Cyberknife Stereotactic
    Que et al. BMC Cancer (2016) 16:451 DOI 10.1186/s12885-016-2512-x RESEARCH ARTICLE Open Access Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma Jenny Que1*, Hsing-Tao Kuo2, Li-Ching Lin1, Kuei-Li Lin1, Chia-Hui Lin1, Yu-Wei Lin1 and Ching-Chieh Yang1 Abstract Background: Stereotactic body radiation therapy (SBRT) has been an emerging non-invasive treatment modality for patients with hepatocellular carcinoma (HCC) when curative treatments cannot be applied. In this study, we report our clinical experience with Cyberknife SBRT for unresectable HCC and evaluate the efficacy and clinical outcomes of this highly sophisticated treatment technology. Methods: Between 2008 and 2012, 115 patients with unresectable HCC treated with Cyberknife SBRT were retrospectively analyzed. Doses ranged from 26 Gy to 40 Gy were given in 3 to 5 fractions for 3 to 5 consecutive days. The cumulative probability of survival was calculated according to the Kaplan-Meier method and compared using log-rank test. Univariate and multivariate analysis were performed using Cox proportional hazard models. Results: The median follow-up was 15.5 months (range, 2-60 months). Based on Response Evaluation and Criteria inSolidTumors(RECIST).Wefoundthat48.7%ofpatients achieved a complete response and 40 % achieved a partial response. Median survival was 15 months (4-25 months). Overall survival (OS) at 1- and 2-years was 63. 5 %(54-71.5 %) and 41.3 % (31.6-50.6 %), respectively, while 1- and 2- years Progression-free Survival (PFS) rates were 42.8 %(33.0-52.2 %) and 38.8 % (29.0-48.4 %).
    [Show full text]
  • 2021 Medical Staff Directory Sentara Rmh Medical Center
    2021 MEDICAL STAFF DIRECTORY SENTARA RMH MEDICAL CENTER sentara.com 98.6° Screening Everyone Masking Everyone Who Enters Who Enters You’re Safe Our Facilities Our Facilities at Sentara In times of uncertainty, trust that Sentara is here to keep our community safe. We are Personal Protective Ongoing, Robust following strict guidelines and have implemented Equipment (PPE) for Cleaning for Infection All Clinicians & Staff Prevention extra safety measures to ensure you are safe while receiving the care you need. When it comes to your health, don’t wait to seek care. You’re safe at Sentara. Virtual Care Ensuring Appointments When Social Appropriate Distancing To learn more about the precautions Sentara is taking to keep you safe, visit sentara.com/safe. Limiting COVID-19 Testing Before Visitors Some Tests & Procedures TELEPHONE DIRECTORY Sentara RMH Medical Center area code for all numbers is 540 Sentara RMH Medical Center ...689-1000 Internal Medicine Physicians ............................ 564-7100 Toll Free ..............................................................877-689-1000 Lab ............................................................................. 689-6600 Admitting ................................................................... 689-1400 Bridgewater Health Center ............................ 515-9109 Anti-Coagulation Clinic .......................................... 689-5976 East Market Street Health Center ................. 689-6600 East Rockingham Health Center ................... 713-4100 Behavioral Health Specialists
    [Show full text]
  • Accelerated Partial Breast Irradiation
    Continuing Medical Education societies regarding the definition of a Intracavitary balloon (Mammosite and Clinical evidence for partial- suitable candidate. Briefly, these include Contura) or strut-based brachytherapy breast irradiation early-stage, low-risk breast cancer: T1 or (SAVI) are another modality of breast The TARGIT, a phase III non- T2 invasive ductal breast carcinoma less brachytherapy. These devices come in The Department of Radiation Oncology offers free Continuing Medical Education credit to readers who read the inferiority trial, compared single-dose than 3 cm; estrogen positive; age greater different sizes, have single or multiple designated CME article and successfully complete a follow-up test online. You can complete the steps necessary targeted intraoperative radiotherapy than 60; and node negative12 (see Table lumens (strut-based or balloon-based to receive your AMA PRA Category 1 Credit(s)™ by visiting (TARGIT) versus fractionated external cme.utsouthwestern.edu/content/target-news- 1 for ASTRO consensus guidelines). catheters), and the entire device is placed beam radiotherapy (EBRT) for breast letter-accelerated-partial-breast-irradiation-apbi-options-and-new-horizons-em150 into the lumpectomy cavity. The lumens cancer.14 From 2000-2012, a total of Treatment options are then connected to an HDR unit, and 3,451 patients were randomized between Partial-breast radiation can be deliv- treatments are given twice daily for five APBI and whole-breast radiation in 33 ered via several different modalities, days to a dose of 34 Gy in 10 fractions. centers in 11 countries. Fifteen percent including interstitial brachytherapy, This treatment is invasive, and the device of women in the APBI arm were treated Accelerated partial breast irradiation (APBI): intracavitary brachytherapy (SAVI, stays within the lumpectomy cavity for the with additional EBRT due to adverse Contura, or Mammosite), intraopera- duration of the radiation treatments (five pathological features.
    [Show full text]
  • (IORT) for Surgically Resected Brain Metastases: Outcome Analysis of an International Cooperative Study
    Journal of Neuro-Oncology https://doi.org/10.1007/s11060-019-03309-6 CLINICAL STUDY Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study Christopher P. Cifarelli1,3 · Stefanie Brehmer5 · John Austin Vargo2 · Joshua D. Hack3 · Klaus Henning Kahl4 · Gustavo Sarria‑Vargas6 · Frank A. Giordano6 Received: 19 August 2019 / Accepted: 5 October 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Background and objective The ideal delivery of radiation to the surgical cavity of brain metastases (BMs) remains the subject of debate. Risks of local failure (LF) and radiation necrosis (RN) have prompted a reappraisal of the timing and/or modality of this critical component of BM management. IORT delivered at the time of resection for BMs requiring surgery ofers the potential for improved local control (LC) aforded by the elimination of delay in time to initiation of radiation following surgery, decreased uncertainty in target delineation, and the possibility of dose escalation beyond that seen in stereotactic radiosurgery (SRS). This study provides a retrospective analysis with identifcation of potential predictors of outcomes. Methods Retrospective data was collected on patients treated with IORT immediately following surgical resection of BMs at three institutions according to the approval of individual IRBs. All patients were treated with 50kV portable linear accelerator using spherical applicators ranging from 1.5 to 4.0 cm. Statistical analyses were performed using IBM SPSS with endpoints of LC, DBC, incidence of RN, and overall survival (OS) and p < 0.05 considered signifcant. Results 54 patients were treated with IORT with a median age of 64 years.
    [Show full text]
  • PRIOR AUTHORIZATION for RADIATION THERAPY For
    PRIOR AUTHORIZATION for RADIATION THERAPY For authorization, please complete this form, include patient chart notes to document information and FAX to the PEHP Prior Authorization Department at (801) 366‐7449 or mail to: 560 East 200 South Salt Lake City, UT 84102. If you have prior authorization or benefit questions, please call PEHP Customer Service at (801) 366‐7555 or toll free at (800) 753‐7490. Section I: PATIENT INFORMATION Name (Last, First MI): DOB: Age: PEHP ID #: Section II: PROVIDER INFORMATION Date Requested: Service Provider Name: Service Provider NPI #: Service Provider Tax ID #: Service Provider Address: Contact Person: Phone: Facsimile: ( ) ( ) Section III: PRE-AUTHORIZATION REQUEST Nature of Request: Please check. Requested Date (s) of Service: Place of Service: Please check. Auth Extension Pre‐Auth Retro Auth Urgent Ambulatory Surgical Center Inpatient Office Outpatient Facility Name: Facility NPI #: Facility Tax ID #: Facility Address: Facility Phone: Facility Facsimile: ( ) ( ) Primary Diagnosis/ICD‐10 Code: Secondary Diagnosis/ICD‐10 Code: A. Stage of Disease (T, N, M): B. Metastatic Site (s): N/A C. Karnofsky/ECOG Score: D. Indication for Radiation Therapy: Please check. Adjuvant Chemoradiation Consolidative Curative Neoadjuvant Palliative Other (please specify): ___________________________ E. Type of Radiation Modality/Technique Being Requested: Please check all that apply. 1. Accelerated 2. Accelerated‐Fractionated 3. Accelerated Partial Breast Irradiation (APBI) 4. Accelerated Whole Breast Irradiation/AWBI 5. Boost 6. Conformal/3D (3D‐CRT) 7. Conventional/2D (2DRT) 8. External Beam/EBRT 9. High Dose/HDR Brachytherapy 10. Hyperfractionated (or Superfractionated) 11. Hypofractionated 12. Image Guided/IGRT 13. Intensity Modulated/IMRT 14. Internal (Brachytherapy) 15. Interstitial Brachytherapy 16.
    [Show full text]
  • Community Health Needs Assessment 2019 Community Health Needs Assessment (CHNA) 2019
    Hospital for Extended Recovery Community Health Needs Assessment 2019 Community Health Needs Assessment (CHNA) 2019 Table of Contents I. Introduction 2 II. Community Description and Demographics 3 III. Health Status Indicators 9 IV. Community Insight 28 V. Prior CHNA Year‐end Progress Report 49 1 Introduction The Hospital for Extended Recovery (HER), as a hospital unit closely associated with Sentara Norfolk General Hospital (SNGH), has participated in the SNGH community health needs assessment of the area that we serve. The assessment provides us with a picture of the health status of the residents in our communities and provides us with information about health and health‐related problems that impact health status. Our assessment includes a review of population characteristics such as age, educational level, and racial and ethnic composition because social factors are important determinants of health. The assessment also looks at risk factors like obesity and smoking and at health indicators such as infant mortality and preventable hospitalizations. Community input is important so the assessment also includes survey results from key stakeholders including public health, social services, service providers, and those who represent underserved populations. The report also includes findings from focus groups with community members on health issues and barriers to achieving good health. While the HER shares some health data with SNGH, we have conducted separate focus groups that represent those in the community most interested in the scope
    [Show full text]
  • Sentara Resolution Agreement and Corrective Action Plan
    RESOLUTION AGREEMENT I. Recitals 1. Parties. The Parties to this Resolution Agreement ("Agreement") are: A.The United States Department of Health and Human Services, Office for Civil Rights ("HHS"), which enforces the Federal standards that govern the privacy of individually identifiable health information (45 C.F.R. Part 160 and Subparts A and E of Part 164, the "Privacy Rule"), the Federal standards that govern the security of electronic individually identifiable health information (45 C.F.R. Part 160 and Subparts A and C of Part 164, the "Security Rule"), and the Federal standards for notification in the case of breach ofunsecured protected health information (45 C.F.R. Part 160 and Subparts A and D of45 C.F.R. Part 164, the "Breach Notification Rule"). HHS has the authority to conduct compliance reviews and investigations of complaints alleging violations ofthe Privacy, Security, and Breach Notification Rules (the "HIPAA Rules") by covered entities and business associates, and covered entities and business associates must cooperate with HHS compliance reviews and investigations. See 45 C.F.R. §§ 160.306(c), 160.308, and 160.310(b). B. Sentara Hospitals, a Virginia nonstock corporation, on behalf of each of the ten (10) covered entity hospitals under its common ownership or control set forth in Appendix A, attached hereto and incorporated by reference, individually as covered entities defined by 45 C.F.R. § 160.103, and collectively as designated part ofthe single Affiliated Covered Entity pursuant to 45 C.F.R. § 164.105(b) (hereinafter collectively referred to as "Sentara Hospitals"). HHS and Sentara Hospitals shall together be referred to herein as_ the "Parties." 2.
    [Show full text]
  • The Future of Radiation Therapy Safe and Innovative Options, Including the Cyberknife® System
    The future of radiation therapy Safe and innovative options, including the CyberKnife® System Could a nonsurgical treatment be right for you? When you’ve been diagnosed with a cancerous or noncancerous tumor, it’s natural to have questions and concerns about your treatment options. While surgery is sometimes the recommended treatment, in many cases, there are nonsurgical options. At CyberKnife® of Long Island, we offer noninvasive radiation therapy treatments that provide benefits over traditional surgery, including: – More comfort – Better accuracy – Fewer side effects – Quicker recovery times With two locations in western Suffolk, our services are also close to home. You have an experienced and Gain the advantage of trusted team dedicated to comprehensive, innovative care your treatment CyberKnife of Long Island is part of the At CyberKnife of Long Island, you can be Northwell Health Cancer Institute, one of confident that you’re being treated by the largest cancer programs in the New York experts in cancer care. metropolitan area. – For almost two decades (originally as We work with a wide range of cancer North Shore Radiation Therapy), we have specialists (nearly 200 members in over been using innovative technology to 25 different specialties). treat a wide variety of cancers, including prostate, lung, brain, skin, breast, head Patients have access to a robust research and and neck, spinal and rectal tumors. clinical trials program and an array of cancer support services — as well as a vast range of – We are the first in Suffolk County to primary care physicians, specialists, emergency use CyberKnife and have been treating rooms, imaging centers, laboratories, home patients with the technology since care and hospice.
    [Show full text]
  • Cyberknife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy
    ORIGINAL RESEARCH ARTICLE published: 21 March 2012 doi: 10.3389/fonc.2012.00025 CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy Jonathan Andrew Haas 1*, Matthew R. Witten2, Owen Clancey 2, Karen Episcopia2, Diane Accordino1 and Eva Chalas 3 1 Division of Radiation Oncology, Winthrop-University Hospital, Mineola, NY, USA 2 Division of Medical Physics, Winthrop-University Hospital, Mineola, NY, USA 3 Division of Gynecologic Oncology, Winthrop-University Hospital, Mineola, NY, USA Edited by: Standard radiation therapy for patients undergoing primary chemosensitized radiation for Brian Timothy Collins, Georgetown carcinomas of the cervix usually consists of external beam radiation followed by an intra- Hospital, USA cavitary brachytherapy boost. On occasion, the brachytherapy boost cannot be performed Reviewed by: Sean Collins, Georgetown University due to unfavorable anatomy or because of coexisting medical conditions. We examined the Hospital, USA safety and efficacy of using CyberKnife stereotactic body radiotherapy (SBRT) as a boost Brian Timothy Collins, Georgetown to the cervix after external beam radiation in those patients unable to have brachytherapy Hospital, USA to give a more effective dose to the cervix than with conventional external beam radiation *Correspondence: alone. Six consecutive patients with anatomic or medical conditions precluding a tandem Jonathan Andrew Haas, Division of Radiation Oncology, and ovoid boost were treated with combined external beam radiation and CyberKnife boost Winthrop-University Hospital, 264 Old to the cervix. Five patients received 45 Gy to the pelvis with serial intensity-modulated radi- Country Road, Mineola, NY 11501, ation therapy boost to the uterus and cervix to a dose of 61.2Gy.These five patients received USA.
    [Show full text]
  • Engaging Health Care Users: a Framework for Healthy Individuals and Communities
    Engaging Health Care Users: A Framework for Healthy Individuals and Communities A Report of the AHA Committe on Research: Benjamin K. Chu, MD, Cheryl Hoying, PhD, RN co-chair Mary J. Kitchell John G. O’Brien, co-chair Stephen Love Rhonda Anderson, DNSc, FACHE Thomas D. O’Connor Thomas L. Bell T.R. Reid Art Blank Michael G. Rock, MD Mary Blunt Jeff Selberg Pamela S. Brier Anthony L. Spezia Lawrence P. Casalino, MD, PhD David P. Tilton Michael Chernew, PhD Richard J. Umbdenstock Douglas A. Conrad, PhD Lorrie Warner Elaine Couture, MBA, RN Maryjane Wurth Brenita Crawford, DHA Steven I. Goldstein American Hospital Association 2012 Committee on Research Benjamin K. Chu, MD Michael Chernew, PhD Thomas D. O’Connor Committee Co-Chair Professor President Regional President Department of Health Care Policy United Hospital Southern California, Kaiser Foundation Harvard Medical School Hospitals T.R. Reid Douglas A. Conrad, PhD Author John G. O’Brien Professor Committee Co-Chair Department of Health Services Michael G. Rock, MD President and Chief Executive Officer University of Washington Chief Medical Officer UMass Memorial Health Care, Inc. Mayo Clinic Hospitals/Mayo Foundation Elaine Couture, BSN, MBA, RN Rhonda Anderson, DNSc, Chief Executive Officer Jeff Selberg FAAN Providence Sacred Heart Executive Vice President and Chief Executive Officer Medical Center Chief Operating Officer Cardon Children’s Medical Center Institute for Healthcare Improvement Brenita Crawford, DHA Thomas L. Bell Retired Healthcare Executive and Educator Anthony L. Spezia President and Chief Executive Officer President and Chief Executive Officer Kansas Hospital Association Steven I. Goldstein Covenant Health President and Chief Executive Officer Art Blank University of Rochester - Strong Memo- David P.
    [Show full text]